T cell activation and human immunodeficiency virus replication after influenza immunization of infected children

Pediatric Infectious Disease Journal

Volumn 15, Issue 3, 1996, Pages 197-203

  Ramilo, Octavio ^a   Hicks, Patricia J ^a   Borvak, Jozef ^a   Gross, Lisa M ^a   Zhong, Danni ^a   Squires, Janet E ^a   Vitetta, Ellen S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

activation; CD25; children; human immunodeficiency virus; immunization; influenza; T cell; viral load

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSTIMULATION; INFANT; INFLUENZA; INFLUENZA VACCINATION; LATENT PERIOD; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIROGENESIS; VIRUS CULTURE; VIRUS REPLICATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HIV; HIV INFECTIONS; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; LYMPHOCYTE ACTIVATION; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; VACCINATION; VIRUS REPLICATION;

EID: 0030005630     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199603000-00004     Document Type: Article

References (25)

1. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991;254:423-7.
2. Schwarting A, Stein H. Activation antigens. In: Knapp W, ed. Leukocyte typing IV. Oxford, U.K.: Oxford University Press, 1991:339.
3. - T cells in acute HIV infection in vitro. J Immunol 1993;150:5202-3.
4. Borvak J, Chou CS, Bell K, et al. Expression of CD25 defines peripheral blood mononuclear cells with productive vs latent HIV infection. J Immunol 1995;155:3196-204.
5. Rosenberg ZF, Fauci AS. Minireview: induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses 1989;5:1-4.
6. Fultz PN, Gluckman JC, Muchmore E, Girard M. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res Hum Retroviruses 1992;8:313-7.
7. Ho DD. HIV-1 viraemia and influenza. [Letter]. Lancet 1992; 339:1549.
8. O'Brien WA, Ovcak S, Kalho H, Mao SH, Zack JA. HIV-1 replication can be increased in blood from seropositive patients following influenza immunization [Abstract PO-A12-0209]. Presented at the IX International Conference on AIDS, Berlin, Germany, June, 1993.
9. Yerly S, Wunderli W, Wyler CA, et al. Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load [Letter]. AIDS 1994;8:1503-4.
10. Hamilton B, Follansbee S, Staprans S, Elbeik T, Feinberg M. Increased HIV plasma viremia after influenza vaccine [Abstract 151]. Presented at the Second National Conference on Human Retroviruses, Washington, DC, January, 1995.
11. Brichacek B, Swindells S, Janoff E, Stevenson M. Immune activation and control of viral burden in AIDS [Abstract 240]. Presented at the Second National Conference on Human Retroviruses, Washington, DC, January, 1995.
12. Peter G, ed. Report of the Committee on Infectious Diseases. American Academy of Pediatrics, 1994:264.
13. Lepage P, Dabis F, Msellati P, et al. Safety and immunogenicity of high dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection: a cohort study in Kigali, Rwanda. Am J Dis Child 1992;146:550-5.
14. Ryder RW, Oxtoby MJ, Mvula M, et al. Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanuspertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 1993;122:697-702.
15. Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994;13:206-11.
16. Zuccotti GV, Riva E, Flumine P, et al. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J Pediatr 1994;125:70-2.
17. Rudy BJ, Rutstein RM, Pinto-Martin J. Responses to measles immunization in children infected with human immunodeficiency virus. J Pediatr 1994;125:72-4.
18. Peters VB, Sood SK. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. J Pediatr 1994;125:74-7.
19. Arpadi SM, Back S, O'Brien J, Janoff J. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. J Pediatr 1994;125:77-9.
20. Zola H, Flego L, Sheldon A. Detection by immunofluorescence of surface molecules present in low copy number: high sensitivity staining and calibration of flow cytometer. J Immunol Methods 1990;135:247-55.
21. Blaine Hollinger F, ed. ACTG Group virology manual for HIV laboratories. Division of AIDS, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, September, 1993.
22. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
23. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-62.
24. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43:1-9.
25. O' Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.